1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ouabain in 8 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ouabain) | Trials (ouabain) | Recent Studies (post-2010) (ouabain) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 16,357 | 72 | 747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braquet, C; Köpernik, W; Mest, HJ; Rein, T; Riedel, A | 1 |
| Barrigón, S; Salinas, P | 1 |
| Garay, RP; Senn, N | 1 |
| Mest, HJ; Riedel, A | 1 |
| Braquet, P; Mest, HJ; Meyer, E; Riedel, A | 1 |
| Braquet, P; Mest, HJ; Riedel, A | 1 |
| Kamata, K; Kasuya, Y; Numazawa, T | 1 |
| Akagawa, Y; Dohi, T; Imai, Y; Itadani, K; Kitayama, S; Morita, K; Yamaki, H | 1 |
8 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ouabain
| Article | Year |
|---|---|
Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Azepines; Clemastine; Coronary Disease; Coronary Vessels; Guinea Pigs; Organoselenium Compounds; Ouabain; Piperidines; Platelet Activating Factor; Propranolol; Rats; Triazoles; Umbelliferones; Ventricular Fibrillation | 1992 |
Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Disease Models, Animal; Drug Synergism; Female; Guinea Pigs; Imidazoles; Lysine; Ouabain; Platelet Activating Factor; Thromboxane-A Synthase | 1991 |
Regulation of Na+ and K+ contents in rat thymocytes.
Topics: Animals; Biological Transport; Blood Coagulation Factors; Bumetanide; Dinoprostone; Hypertension; Isoproterenol; Kinetics; Male; Ouabain; Platelet Activating Factor; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Sodium; Sodium Channels; T-Lymphocytes | 1989 |
The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites.
Topics: Animals; Arachidonic Acids; Arrhythmias, Cardiac; Aspirin; Fibrinolytic Agents; Guinea Pigs; Lipoxygenase Inhibitors; Ouabain; Platelet Activating Factor; Sulfonamides; Umbelliferones | 1987 |
The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids.
Topics: Aconitic Acid; Animals; Arrhythmias, Cardiac; Diazepam; Diltiazem; Dogs; Guinea Pigs; Imidazoles; Myocardial Contraction; Naphthalenes; Ouabain; Platelet Activating Factor; Pyrimidines; Rats; Reference Values; Trapidil | 1988 |
The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Diltiazem; Diterpenes; Ginkgolides; Guinea Pigs; In Vitro Techniques; Injections, Intravenous; Lactones; Ouabain; Platelet Activating Factor | 1987 |
Characteristics of vasodilatation induced by acetylcholine and platelet-activating factor in the rat mesenteric arterial bed.
Topics: Acetylcholine; Animals; Dose-Response Relationship, Drug; Male; Mesenteric Arteries; Ouabain; Platelet Activating Factor; Rats; Rats, Wistar; Vasodilation | 1996 |
Inhibition of Na+,K(+)-ATPase by platelet-activating factor in dog submandibular glands.
Topics: Animals; Azepines; Binding Sites; Dogs; Membrane Proteins; Mucins; Ouabain; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sodium-Potassium-Exchanging ATPase; Subcellular Fractions; Submandibular Gland; Triazoles | 1998 |